HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer-Reference-Cited by-同舟云学术

HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer

Published:2008-12-01 Issue:23 Volume:14 Page:7861-7870
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Press Michael F.,Finn Richard S.,Cameron David,Di Leo Angelo,Geyer Charles E.,Villalobos Ivonne E.,Santiago Angela,Guzman Roberta,Gasparyan Armen,Ma Yanling,Danenberg Kathy,Martin Anne Marie,Williams Lisa,Oliva Cristina,Stein Steven,Gagnon Robert,Arbushites Michael,Koehler Maria T.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response;Cell Reports Medicine;2024-05

2. Personalized Medicine in Clinical Management of Breast Cancer: Where Do We Stand?;Molecular Biomarkers for Cancer Diagnosis and Therapy;2024

3. Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis;Frontiers in Pharmacology;2023-06-22

4. HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry;Cancer Cell International;2022-11-15

5. A round table discussion: clinical landscape of trastuzumab deruxtecan in breast cancer: a retrospective and prospective view;Translational Breast Cancer Research;2022-10